Trade

with

Volcano Corp
(NASDAQ: VOLC)
AdChoices
11.14
+0.37
+3.44%
After Hours :
11.14
0.00
0.00%

Open

10.74

Previous Close

10.77

Volume (Avg)

389.41k (739.94k)

Day's Range

10.74-11.33

52Wk Range

10.10-24.62

Market Cap.

554.23M

Dividend Rate ( Yield )

-

Beta

0.29

Shares Outstanding

51.46M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 393.68M

    • Net Income

    • -34.49M

    • Market Cap.

    • 554.23M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -9.99

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.29

    • Forward P/E

    • -277.78

    • Price/Sales

    • 1.44

    • Price/Book Value

    • 1.80

    • Price/Cash flow

    • 58.48

      • EBITDA

      • 2.45M

      • Return on Capital %

      • -4.42

      • Return on Equity %

      • -10.98

      • Return on Assets %

      • -4.42

      • Book Value/Share

      • 5.97

      • Shares Outstanding

      • 51.46M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 18.40

        • Credit Rating

        • -

        • Analysts

        • 6

        • EPS Estimate

        • -0.29

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 1.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 18.08

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 62.92

            • 64.08

            • Pre-Tax Margin

            • -13.74

            • 15.19

            • Net Profit Margin

            • -9.99

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 63.90

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -3.00

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -1.30

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.34

              • 0.34

              • Current Ratio

              • 4.00

              • 2.55

              • Quick Ratio

              • 3.00

              • 1.83

              • Interest Coverage

              • -0.93

              • 11.70

              • Leverage Ratio

              • 2.87

              • 1.86

              • Book Value/Share

              • 5.97

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -14.84

                • 32.79

                • P/E Ratio 5-Year High

                • -45.38

                • 224.03

                • P/E Ratio 5-Year Low

                • -13.52

                • 60.23

                • Price/Sales Ratio

                • 1.48

                • 3.07

                • Price/Book Value

                • 1.86

                • 3.10

                • Price/Cash Flow Ratio

                • 58.48

                • 17.86

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -10.98

                        (-1.20)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -4.42

                        (-0.70)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -2.50

                        (-2.00)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 2.26

                      • 2.77

                      • Asset Turnover

                      • 0.44

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -29.90M
                      Operating Margin
                      -7.60
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      58.48
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      73.87%

                      Mutual Fund Ownership

                      65.14%

                      Float

                      88.06%

                      5% / Insider Ownership

                      2.88%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • AZ InvestEd Ivy Science & Tech Fund

                      •  

                        3,192,300

                      • 10.54

                      • 6.23

                      • Ivy Science and Technology Fund

                      •  

                        3,192,300

                      • 0.00

                      • 6.22

                      • Waddell & Reed Advisor Science And Techn

                      •  

                        2,156,100

                      • 0.00

                      • 4.20

                      • Champlain - Small Cap Equity

                      •  

                        2,132,470

                      • 0.88

                      • 4.16

                      • T. Rowe Price Health Sciences Fund

                      •  

                        1,497,607

                      • -0.31

                      • 2.92

                      • T. Rowe Price New Horizons Fund

                      •  

                        1,435,900

                      • -0.10

                      • 2.80

                      • Manning & Napier Equity Series Fund

                      •  

                        1,354,150

                      • 0.00

                      • 2.63

                      • Fidelity® Select Health Care Portfolio

                      •  

                        1,100,000

                      • -8.33

                      • 2.14

                      • GAM Star US All Cap Equity

                      •  

                        1,057,610

                      • 23.76

                      • 2.05

                      • T. Rowe Price Small Cap Stock Fund

                      •  

                        1,012,600

                      • -0.49

                      • 1.97

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Manning & Napier Advisors, LLC

                      •  

                        5,961,507

                      • +25.93%

                      • 11.58

                      • Waddell & Reed Investment Management Co

                      •  

                        5,725,600

                      • +0.93%

                      • 11.16

                      • Camber Capital Management LLC

                      •  

                        5,050,000

                      • +60.32%

                      • 9.81

                      • T. Rowe Price Associates, Inc.

                      •  

                        5,029,410

                      • -0.40%

                      • 9.80

                      • Vanguard Group, Inc.

                      •  

                        3,165,650

                      • -2.89%

                      • 6.17

                      • Wellington Management Company, LLP

                      •  

                        3,019,660

                      • +0.29%

                      • 5.88

                      • TimesSquare Capital Management, LLC

                      •  

                        2,854,850

                      • +17.84%

                      • 5.56

                      • Fidelity Management and Research Company

                      •  

                        2,805,191

                      • -35.43%

                      • 5.47

                      • Champlain Investment Partners, LLC

                      •  

                        2,294,175

                      • +0.83%

                      • 4.47

                      • Engaged Capital Holdings LLC

                      •  

                        2,042,403

                      • -13.91%

                      • 3.97

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      Volcano Corp incorporated in the state of Delaware in January 2000. The Company completed its initial public offering on June 15, 2006. The Company designs, develops, manufactures and commercializes a broad suite of precision guided ...moretherapy tools including intravascular ultrasound, or IVUS, and fractional flow reserve, or FFR, products. The IVUS products include single-procedure disposable phased array and rotational IVUS imaging catheters, and additional functionality options such as ChromaFlo stent apposition analysis. FFR offerings can be accessed through its multi-modality platforms, and it also provide FFR-only consoles. Its products include: IVUS Products, Catheters, its single-use disposable catheters operate and interface solely with its family of consoles. Catheters, its single-use disposab...morele catheters operate and interface solely with its family of consoles. ChromaFlo stent apposition analysis technology uses sequential IVUS frames to differentiate circulating blood from stationary or anchored tissue. SyncVision, Sync-Rx Ltd, or Sync-Rx, an Israel-based company that develops advanced software applications designed to optimize and facilitate trans-catheter cardiovascular interventions using automated online image processing. FFR products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The Company’s primary imaging competitors globally are Boston Scientific, Inc., or Boston Scientific, with its IVUS offering and St. Jude Medical, Inc., or St. Jude with its OCT offering. In Japan, it also competes with Terumo Corporation, which offers both IVUS and OCT. In the FFR market, its primary competitor is St. Jude. Because of the size of the vascular market opportunities, competitors and potential competitors have dedicated and will continue to dedicate significant resources to aggressively promote their products. It has registered and common law trademarks in the U.S. and elsewhere in the world including, but not limited to, Aim, Axsun, Bi-Trieval, Centriq, ChromaFlo, ComboMap, ComboWire, Core, Crux, Crux Biomedical, Define, Eagle Eye, ETNA, FACT, FloMap, FloWire, Ginko, GlyDx, Hi-Q, iFR, In-Line Digital, Instant Wave-Free Ratio, Intentio, Octave, pcFM, Precision Guided Therapy, PreView, PrimeWire, PrimeWire Prestige, ReFlow, Revolution, SlyDx, s5i, SmartMap, SpinVision, Sync-Rx, Trak Back, Valet, Verrata, VH, VIBE, Virtual Histology, Visions, Volcano, Wavewire, Xtract and Zuum. The Company’s medical device products are subject to extensive and rigorous regulation by the FDA, as well as other federal and state regulatory bodies in the U.S. and comparable authorities in other countries.lessless

                      Key People

                      R. Scott Huennekens

                      CEO/President/Director

                      Ronald A. Matricaria

                      Chairman of the Board/Director

                      John T. Dahldorf

                      CFO/Chief Accounting Officer

                      John Onopchenko

                      Executive VP, Divisional

                      Mr. Darin Lippoldt

                      Executive VP/General Counsel/Other Executive Officer/Secretary

                      • Volcano Corp

                      • 3721 Valley Centre Drive

                      • San Diego, CA 92130

                      • USA.Map

                      • Phone: +1 800 228-4728

                      • Fax: +1 858 720-0325

                      • volcanocorp.com

                      Incorporated

                      2000

                      Employees

                      1,800

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: